These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 11337603)

  • 1. Multiple sclerosis and age at infection with common viruses.
    Hernán MA; Zhang SM; Lipworth L; Olek MJ; Ascherio A
    Epidemiology; 2001 May; 12(3):301-6. PubMed ID: 11337603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis and antecedent infections.
    Wolfson C
    Epidemiology; 2001 May; 12(3):298-9. PubMed ID: 11337601
    [No Abstract]   [Full Text] [Related]  

  • 3. Siblings reduce multiple sclerosis risk by preventing delayed primary Epstein-Barr virus infection.
    Rostgaard K; Nielsen NM; Melbye M; Frisch M; Hjalgrim H
    Brain; 2023 May; 146(5):1993-2002. PubMed ID: 36317463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis.
    Thacker EL; Mirzaei F; Ascherio A
    Ann Neurol; 2006 Mar; 59(3):499-503. PubMed ID: 16502434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: no.
    Salzer J; Myhr KM
    Mult Scler; 2013 Nov; 19(13):1692-3. PubMed ID: 24218487
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epstein-Barr virus and disseminated sclerosis: causative or secondary associations?].
    Munch M; Haahr S; Höllsberg P
    Ugeskr Laeger; 2002 Dec; 164(50):5903-4. PubMed ID: 12553105
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple sclerosis after infectious mononucleosis.
    Nielsen TR; Rostgaard K; Nielsen NM; Koch-Henriksen N; Haahr S; Sørensen PS; Hjalgrim H
    Arch Neurol; 2007 Jan; 64(1):72-5. PubMed ID: 17210811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
    Lucas RM; Ponsonby AL; Dear K; Valery P; Pender MP; Burrows JM; Burrows SR; Chapman C; Coulthard A; Dwyer DE; Dwyer T; Kilpatrick T; Lay ML; McMichael AJ; Taylor BV; van der Mei IA; Williams D
    Neurology; 2011 Jul; 77(4):371-9. PubMed ID: 21753179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Infectious Mononucleosis in Childhood and Adolescence With Risk for a Subsequent Multiple Sclerosis Diagnosis Among Siblings.
    Xu Y; Hiyoshi A; Smith KA; Piehl F; Olsson T; Fall K; Montgomery S
    JAMA Netw Open; 2021 Oct; 4(10):e2124932. PubMed ID: 34633426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for viral etiology of multiple sclerosis.
    Tselis A
    Semin Neurol; 2011 Jul; 31(3):307-16. PubMed ID: 21964847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood infections and risk of multiple sclerosis.
    Bager P; Nielsen NM; Bihrmann K; Frisch M; Hjalgrim H; Wohlfart J; Koch-Henriksen N; Melbye M; Westergaard T
    Brain; 2004 Nov; 127(Pt 11):2491-7. PubMed ID: 15371288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus candidate genes and multiple sclerosis.
    Claire Simon K; Schmidt H; Loud S; Ascherio A
    Mult Scler Relat Disord; 2015 Jan; 4(1):60-4. PubMed ID: 25787055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study.
    Gustavsen MW; Page CM; Moen SM; Bjølgerud A; Berg-Hansen P; Nygaard GO; Sandvik L; Lie BA; Celius EG; Harbo HF
    BMC Neurol; 2014 Oct; 14():196. PubMed ID: 25274070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis.
    Jons D; Sundström P; Andersen O
    Acta Neurol Scand; 2015 Feb; 131(2):69-79. PubMed ID: 25208981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple sclerosis and the history of infectious diseases in childhood].
    Wender M; Zwyrzykowska-Kierys E
    Neurol Neurochir Pol; 1984; 18(5):429-34. PubMed ID: 6527724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of paramyxoviruses in multiple sclerosis.
    Cook SD; Blumberg B; Dowling PC
    Neurol Clin; 1986 Feb; 4(1):303-19. PubMed ID: 3724739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.
    Lossius A; Riise T; Pugliatti M; Bjørnevik K; Casetta I; Drulovic J; Granieri E; Kampman MT; Landtblom AM; Lauer K; Magalhaes S; Myhr KM; Pekmezovic T; Wesnes K; Wolfson C; Holmøy T
    Mult Scler; 2014 May; 20(6):669-74. PubMed ID: 24072723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis after infectious mononucleosis: record linkage study.
    Goldacre MJ; Wotton CJ; Seagroatt V; Yeates D
    J Epidemiol Community Health; 2004 Dec; 58(12):1032-5. PubMed ID: 15547068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis.
    Wagner HJ; Munger KL; Ascherio A
    Eur J Neurol; 2004 Dec; 11(12):833-4. PubMed ID: 15667414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.